English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative neoplasm

MPS-Authors

Chmielecki,  Juliann
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

/persons/resource/persons147255

Peifer,  Martin
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Viale,  Agnes
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Hutchinson,  Katherine
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Giltnane,  Jennifer
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Socci,  Nicholas D.
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Dean,  Rebecca S.
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Yenamandra,  Ashwini
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Jagasia,  Madan
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Kim,  Annette S.
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Davé,  Utpal P.
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

/persons/resource/persons147315

Thomas,  Roman K.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Pao,  William
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

External Ressource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Chmielecki, J., Peifer, M., Viale, A., Hutchinson, K., Giltnane, J., Socci, N. D., et al. (2012). Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative neoplasm. Genes Chromosomes and Cancer, 51(1), 54-65. doi:10.1002/gcc.20930.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0026-D996-F
Abstract
© 2011 Wiley-Liss, Inc.